Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu, 610041, Sichuan, China.
Aging Clin Exp Res. 2018 Sep;30(9):1071-1077. doi: 10.1007/s40520-017-0881-x. Epub 2017 Dec 19.
Statins therapy in the secondary prevention of coronary artery disease (CAD) is associated with a lower risk of adverse cardiovascular events. However, little is known regarding the association of elderly patients with nutritional risk on statin therapy.
To investigate whether older patients with CAD who were at nutritional risk gain similar survival benefit from statins therapy as their counterparts without nutritional risk.
We conducted a retrospective hospital-based cohort study among 1705 patients with CAD who were older than 65 years of age, using coronary heart disease database from 2008 to 2012. Nutritional status of included patients was gauged using the geriatric nutritional risk index. After stratification by nutritional status, the hazard of all-cause death was compared between those with or without statins therapy.
Of the 1705 patients included in the study (mean age 72 years; 73% male), all-cause death occurred in 146 (9.2%) patients with statins use and in 33 (26.2%) patients without statins use. The rate of all-cause death was higher in patients not receiving statins irrespective of nutritional status. After adjustments for potential confounders, the HR with statins use was 0.33 (95% CI 0.20-0.55) in patients without nutritional risk and 0.47 (95% CI 0.22-1.00) in patients with nutritional risk. No interaction effect was detected between nutritional status and statins use in relation to all-cause death (P value for interaction effect 0.516).
Despite of the patient's nutritional status, statins therapy as a secondary prevention in elderly CAD patients was associated with decreased risk of all-cause death.
他汀类药物治疗在冠心病(CAD)的二级预防中与降低不良心血管事件的风险相关。然而,对于患有营养风险的老年患者在他汀类药物治疗中的获益知之甚少。
调查患有 CAD 的老年患者是否存在营养风险,他们从他汀类药物治疗中获得的生存获益与无营养风险的患者相似。
我们对 2008 年至 2012 年冠心病数据库中年龄大于 65 岁的 1705 例 CAD 患者进行了回顾性基于医院的队列研究。采用老年营养风险指数评估纳入患者的营养状况。根据营养状况分层后,比较有或无他汀类药物治疗的患者全因死亡的风险。
在纳入的 1705 例患者中(平均年龄 72 岁,73%为男性),146 例(9.2%)接受他汀类药物治疗的患者和 33 例(26.2%)未接受他汀类药物治疗的患者发生了全因死亡。无论营养状况如何,未接受他汀类药物治疗的患者全因死亡率均较高。调整潜在混杂因素后,无营养风险的患者中他汀类药物治疗的 HR 为 0.33(95%CI 0.20-0.55),有营养风险的患者为 0.47(95%CI 0.22-1.00)。在全因死亡方面,未检测到营养状况和他汀类药物使用之间的交互作用效应(交互作用效应 P 值为 0.516)。
尽管患者存在营养状况,但他汀类药物治疗作为老年 CAD 患者的二级预防措施与降低全因死亡风险相关。